Frank Mccormick Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Frank Mccormick is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 83 shares of BBIO, which is worth approximately $3,816. The most recent transaction as insider was on Jun 20, 2025, when has been sold 6,589 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83
99.98% 3M change
99.99% 12M change
Total Value Held $3,816

FRANK MCCORMICK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2025
BUY
Grant, award, or other acquisition
-
6,589 Added 98.76%
83 Common Stock
May 08 2025
SELL
Bona fide gift
-
3,000 Reduced 3.76%
76,686 Common Stock
May 07 2025
SELL
Bona fide gift
-
33,000 Reduced 29.28%
79,686 Common Stock
Dec 26 2024
SELL
Bona fide gift
-
7,400 Reduced 1.57%
464,976 Common Stock
Nov 13 2020
SELL
Open market or private sale
$4,290,000 $42.9 p/Share
100,000 Reduced 7.69%
1,200,468 Common Stock

Also insider at

OLMA
Olema Pharmaceuticals, Inc. Healthcare
Director
FM

Frank Mccormick

San Francisco, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO